CVS is now covering long-acting injectable PrEP, representing a shift from last year when the pharmacy giant announced it was ...

Kenya will this year begin rolling out a new long-acting injectable HIV prevention drug, Lenacapavir, positioning the country ...

Australia's taken another step in HIV prevention, with the TGA approving long-acting drug lenacapavir—but access is vital, ...

Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden administration announced October 21. The news comes just weeks after it was announced ...

LOS ANGELES, December 24, 2024--(BUSINESS WIRE)--In light of the recently announced plan to put 2.5 million people on injectable pre-exposure prophylaxis (PrEP), specifically lenacapavir, by 2027, ...

After Thailand, Cambodia becomes the second Asian country to rollout long-acting and injectable options to protect oneself from getting infected with HIV. United Nations health agency (formally known ...

Injectable PrEP is coming to the UK, as the National Institute for Health and Care Excellence (NICE) has approved cabotegravir (Apretude) – a groundbreaking development against HIV/AIDS. The rollout ...

At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...

The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their policies without a co-payment for consumers. The new rule, built on ...

The Biden administration on Oct. 21 issued a new proposed rule that would require health insurance providers to cover an injectable form of the HIV prevention medication known as PrEP, marking a ...

Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past decade. Pre-exposure prophylaxis (PrEP) with antiretroviral medications is ...